Bayer Inc — licence 101029, currently licensed, last inspection rating C (2023-02-07).
No Canadian shortage report is currently matched to this DIN.
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02484587 | AG-VARDENAFIL | ANGITA PHARMA INC. | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 5 MG | Approved |
| 02484609 | AG-VARDENAFIL | ANGITA PHARMA INC. | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 20 MG | Approved |
| 02484595 | AG-VARDENAFIL | ANGITA PHARMA INC. | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 10 MG | Approved |
| 02471647 | APO-VARDENAFIL | APOTEX INC | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 5 MG | Marketed |
| 02471655 | APO-VARDENAFIL | APOTEX INC | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 10 MG | Marketed |
| 02471663 | APO-VARDENAFIL | APOTEX INC | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 20 MG | Marketed |
| 02475677 | JAMP-VARDENAFIL | JAMP PHARMA CORPORATION | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 5 MG | Marketed |
| 02475685 | JAMP-VARDENAFIL | JAMP PHARMA CORPORATION | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 10 MG | Marketed |
| 02475693 | JAMP-VARDENAFIL | JAMP PHARMA CORPORATION | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 20 MG | Marketed |
| 02250462 | LEVITRA | BAYER INC | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02250489 | LEVITRA | BAYER INC | Tablet | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 20 MG | Cancelled Post Market |
| 02372436 | STAXYN | BAYER INC | Tablet (Orally-Disintegrating) | VARDENAFIL (VARDENAFIL HYDROCHLORIDE) 10 MG | Cancelled Post Market |